Cross-talk between QseBC and PmrAB two-component systems is crucial for regulation of motility and colistin resistance in Enteropathogenic Escherichia coli
PLOS Pathogens · 07.12.2023 · 19 (12) · e1011345
DOI: 10.1371/journal.ppat.1011345 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 07.12.2023. Verfasst von Blanca Fernandez-Ciruelos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Host-Microbe Interactomics Group, Wageningen University & Research (WUR), Wageningen, The Netherlands. Hauptthemen laut MEDLINE: Enteropathogenic Escherichia coli, Escherichia coli Proteins. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: H2020 Marie Skłodowska-Curie Actions.
Abstract (Originalsprache)
The quorum sensing two-component system (TCS) QseBC has been linked to virulence, motility and metabolism regulation in multiple Gram-negative pathogens, including Enterohaemorrhagic Escherichia coli (EHEC), Uropathogenic E . coli (UPEC) and Salmonella enterica . In EHEC, the sensor histidine kinase (HK) QseC detects the quorum sensing signalling molecule AI-3 and also acts as an adrenergic sensor binding host epinephrine and norepinephrine. Downstream changes in gene expression are mediated by phosphorylation of its cognate response regulator (RR) QseB, and ʻcross-talksʼ with non-cognate regulators KdpE and QseF to activate motility and virulence. In UPEC, cross-talk between QseBC and TCS PmrAB is crucial in the regulation and phosphorylation of QseB RR that acts as a repressor of multiple pathways, including motility. Here, we investigated QseBC regulation of motility in the atypical Enteropathogenic E . coli (EPEC) strain O125ac:H6, causative agent of persistent diarrhoea in children, and its possible cross-talk with the KdpDE and PmrAB TCS. We showed that in EPEC QseB acts as a repressor of genes involved in motility, virulence and stress response, and in absence of QseC HK, QseB is likely activated by the non-cognate PmrB HK, similarly to UPEC. We show that in absence of QseC, phosphorylated QseB activates its own expression, and is responsible for the low motility phenotypes seen in a QseC deletion mutant. Furthermore, we showed that KdpD HK regulates motility in an independent manner to QseBC and through a third unidentified party different to its own response regulator KdpE. We showed that PmrAB has a role in iron adaptation independent to QseBC. Finally, we showed that QseB is the responsible for activation of colistin and polymyxin B resistance genes while PmrA RR acts by preventing QseB activation of these resistance genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Host-Microbe Interactomics Group, Wageningen University & Research (WUR), Wageningen, The Netherlands.
- Organic Synthesis Methodology Group, Latvian Institute of Organic Synthesis (LIOS), Riga, Latvia.
ORCID-Profile: Blanca Fernandez-Ciruelos
Förderung
- H2020 Marie Skłodowska-Curie Actions
Zitieren
APA
Fernandez-Ciruelos, B., Potmis, T., Solomin, V., & Wells, J. M. (2023). Cross-talk between QseBC and PmrAB two-component systems is crucial for regulation of motility and colistin resistance in Enteropathogenic Escherichia coli. PLOS Pathogens, 19(12), e1011345. https://doi.org/10.1371/journal.ppat.1011345
Vancouver
Fernandez-Ciruelos B, Potmis T, Solomin V, Wells JM. Cross-talk between QseBC and PmrAB two-component systems is crucial for regulation of motility and colistin resistance in Enteropathogenic Escherichia coli. PLOS Pathogens. 2023;19(12):e1011345. doi:10.1371/journal.ppat.1011345
BibTeX
@article{FernandezCiruelos2023,
author = {Fernandez-Ciruelos, Blanca and Potmis, Tasneemah and Solomin, Vitalii and Wells, Jerry M},
title = {Cross-talk between QseBC and PmrAB two-component systems is crucial for regulation of motility and colistin resistance in Enteropathogenic Escherichia coli},
journal = {PLOS Pathogens},
year = {2023},
volume = {19},
number = {12},
pages = {e1011345},
doi = {10.1371/journal.ppat.1011345}
}
EUVIMED